According to the latest Global Cancer Data for 2020 released by the World Health Organization's International Agency for Research on Cancer (IARC), the number of new cancer cases worldwide is estimated to increase from 19.3 million to 30.2 million in next 20 years due to increasing population aging. Clinical studies have shown that early and precise cancer theranostics can effectively reduce patient mortality. In recent years, nanoagents have been widely applied in the field of cancer theranostics owing to their inherent passive and active targeting effect on cancerous tissues. Among various kinds of theranostic nanoagents, polymer nanoagents have attracted extensive interests from researchers in terms of their excellent biocompatibility, easy processability, and flexible surface functionalization.
Despite great progress achieved in the development of advanced polymer nanoagents for cancer theranostics, there are still lots of issues remaining to be addressed. For instance, the development of new strategies to regulate the performance of fluorescent and photoacoustic probes, new theories to guide the design of novel phosphorescent and chemiluminescent probes, new cancer therapy strategies, new ideas how to better combine diagnostic and therapeutic functions into a single system, and last but not least, how to better deliver therapeutic nanoagents to tumour sites. In this Research Topic, we aim to cover recent advances that focus on the nanostructure design of novel polymer nanoagents and their effect on cancer theranostics.
We welcome Original Research, Review, Mini Review and Perspective articles on themes including, but not limited to:
• Design and preparation of polymer nanoprobe for cancer diagnosis / image-guided tumour resection
• Design and construction of polymer nanomedicine for cancer theranostics
• Design of Nanostructures for Theranostics Applications
• Cancer immunotherapy applications of polymer nanoagents
• Novel polymer nanoagents-based approach for cancer therapy
According to the latest Global Cancer Data for 2020 released by the World Health Organization's International Agency for Research on Cancer (IARC), the number of new cancer cases worldwide is estimated to increase from 19.3 million to 30.2 million in next 20 years due to increasing population aging. Clinical studies have shown that early and precise cancer theranostics can effectively reduce patient mortality. In recent years, nanoagents have been widely applied in the field of cancer theranostics owing to their inherent passive and active targeting effect on cancerous tissues. Among various kinds of theranostic nanoagents, polymer nanoagents have attracted extensive interests from researchers in terms of their excellent biocompatibility, easy processability, and flexible surface functionalization.
Despite great progress achieved in the development of advanced polymer nanoagents for cancer theranostics, there are still lots of issues remaining to be addressed. For instance, the development of new strategies to regulate the performance of fluorescent and photoacoustic probes, new theories to guide the design of novel phosphorescent and chemiluminescent probes, new cancer therapy strategies, new ideas how to better combine diagnostic and therapeutic functions into a single system, and last but not least, how to better deliver therapeutic nanoagents to tumour sites. In this Research Topic, we aim to cover recent advances that focus on the nanostructure design of novel polymer nanoagents and their effect on cancer theranostics.
We welcome Original Research, Review, Mini Review and Perspective articles on themes including, but not limited to:
• Design and preparation of polymer nanoprobe for cancer diagnosis / image-guided tumour resection
• Design and construction of polymer nanomedicine for cancer theranostics
• Design of Nanostructures for Theranostics Applications
• Cancer immunotherapy applications of polymer nanoagents
• Novel polymer nanoagents-based approach for cancer therapy
